The Breakthrough T1D is requesting applications to support the development of tolerance induction approaches for islet cell therapy that enables graft-specific immune protection without compromising natural immune defences. This funding opportunity supports both central and peripheral tolerance induction strategies aimed at advancing clinically translatable approaches for improving islet replacement therapies in T1D. Grants of up
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: